Homeo AI Blog ยท 2026-08-24

Homeo AI vs Aquanta simili.ai: Bayesian Ranking or Review Copilot?

Compare Aquanta simili.ai's Bayesian remedy ranking and vendor validation claims with Homeo AI's inspectable case-review workflow.

See Homeo AI in your workflow

Choose a time for a guided walkthrough, or open the app if you already have an account.

Book a call on Calendly - open the full scheduling calendar and choose the time that works for you.

Log in to the Homeo AI app - continue your saved case and follow-up workflow.

A 3-day trial is available only to first-time users who have not tried Homeo AI before.

Quick answer

Choose Aquanta simili.ai when the narrow test is multilingual Bayesian remedy ranking with an optional AI review and the practitioner is prepared to validate the vendor's evidence claims. Choose Homeo AI when the main job is to preserve a completed case narrative, inspect proposed symptom and rubric structure, open supporting source passages, correct the differential, and keep the accepted reasoning available for follow-up.

Aquanta's public product page and its linked application now tell different commercial and device stories. On 18 October 2026, the product page advertised ten free consultations per month and said the service works on desktop and mobile. The linked application still labelled itself Beta, advertised free access with a maximum of ten cases per day, and warned that it was designed for desktop browsers with limited mobile support. Neither public surface identifies which offer governs. Confirm the applicable limit and device support in writing before relying on either claim.

The product page also makes new performance claims: more than 1,700 blind-tested cases, top-one accuracy above 40%, top-five accuracy above 70%, and a combined top-ten rate above 90% with Expert Review. These figures are vendor-published summaries, not an independent audit. Aquanta's separate 2026 preprint studies semantic alignment between historical proving descriptions and modern toxicology signs. It does not validate the live product, prove therapeutic efficacy, or establish that a ranked remedy is clinically correct. Keep the product claim, the vendor-authored study, and independent product validation as separate evidence categories.

What the current product pages offer

Aquanta describes a Bayesian ensemble combined with an optional AI Expert Review. The current site says the ranking uses more than 455,000 symptom-remedy likelihood relationships. Separately, it says narrative symptoms are mapped to classical rubrics from Kent, Hering, Boericke, Allen, and Lippe. It accepts case descriptions in multiple languages and asks differentiating follow-up questions. The product page says the Bayesian modes are fused through reciprocal rank fusion and that the AI review independently challenges or refines the list.

These are vendor statements to test. A large relationship count does not establish source completeness, edition control, transcription quality, or clinical validity. Reciprocal rank fusion combines ranked lists; it does not turn uncertain inputs into a probability of benefit. Ask Aquanta to identify the precise source editions, transformation process, exclusions, error review, update policy, and version attached to each case report.

Bayesian ranking can be useful when its inputs, assumptions, and likelihood updates are visible enough to challenge. Ask what a displayed confidence measure means. It may represent a normalized ranking, model certainty, rubric coverage, or another internal quantity. It should not be read as the probability that a remedy will help a patient. Repeat a case after small wording changes and record whether ranking changes are stable and explainable.

The conflicting allowance statements make procurement less clear. Ten consultations per month and ten cases per day differ by roughly an order of magnitude. Confirm which counter applies, whether editing and rerunning consumes another allowance, whether the offer is account-specific, and what happens if beta terms change. Free access is the current public offer, but the reviewed pages do not establish long-term terms. Do not budget from either public limit until checkout or written terms identify the governing offer.

What the preprint does and does not show

Aquanta's vendor preprint compares historical homeopathic proving descriptions with modern toxicology signs using language-model embeddings. It describes a larger remedy set, a gated analysis subset, statistical correction, and a group of remedies that passed its significance threshold. The research question is about semantic coherence between two bodies of text.

That is not the same question as whether simili.ai selects a clinically appropriate remedy from a real case. The paper does not test patient outcomes, therapeutic efficacy, the live interface, error rates in narrative interpretation, practitioner correction, follow-up decisions, or comparative safety. It should not be cited as evidence that the product works clinically or as validation of the newer 1,700-case performance claims.

The paper's own limitations are important for procurement. Semantic similarity is not clinical validity. The selection gate changes which remedies enter the final analysis. A language model was involved in the research pipeline, which creates a possible circularity when related language representations are compared. The embedding model was not medically validated for this use. Code and data are described as available on request rather than as an independently reproducible public package in the reviewed materials.

This does not make the research worthless. It makes the correct claim narrower: Aquanta provides a vendor-authored statistical and semantic rationale that can inform questions for a product trial. The current product page names three journal sources around its case-testing table, but a buyer still needs the case list, inclusion rules, reference answer, evaluation protocol, model version, error analysis, and reproducible results before treating the summary as product validation.

How Homeo AI differs

Homeo AI centers the review path rather than a single Bayesian rank. The practitioner starts with an approved narrative, checks proposed symptom structure and rubric mappings, edits or rejects them, opens linked passages, reviews remedy differences, and preserves the accepted rationale for follow-up. Its value depends on whether the transformation can be reconstructed and corrected.

Homeo AI should not be described as using Aquanta's Bayesian method or validated by Aquanta's preprint. Aquanta should not be assumed to reproduce Homeo AI's exact correction trail merely because it accepts symptom language, uses AI, or presents confidence information. The two products make different promises that require different tests.

See the workflow live

Choose a time for a guided walkthrough, or open the app if you already have an account.

Book a call on Calendly - open the full scheduling calendar and choose the time that works for you.

Log in to the Homeo AI app - continue your saved case and follow-up workflow.

A 3-day trial is available only to first-time users who have not tried Homeo AI before.

If the clinic wants a fast Bayesian-ranked list with a separate AI challenge step, Aquanta may be the clearer experiment. If the clinic wants another practitioner to see why ordinary wording became a symptom and rubric structure, challenge the source passages, and compare follow-up changes, Homeo AI may fit the narrower review job.

Data and governance questions

Aquanta's public footer describes simili.ai as educational and not diagnostic. The reviewed product, about, and linked application pages still did not expose separate public privacy or terms documents. Do not infer that no internal controls exist. The absence of a reviewable public agreement means a practitioner needs written answers before entering any information that could identify a person.

Ask which entity operates simili.rmlx.cloud, where prompts and accounts are hosted, which subprocessors and model providers receive content, whether inputs or outputs are retained or used for training, how long logs and backups remain, and how export and deletion work. Ask whether the product stores cases by default, whether a user can remove them, what staff can inspect for support, and what notice will be given before the beta changes or closes.

Use only completed, de-identified cases. Remove names, dates of birth, contact details, record numbers, exact visit dates, photographs, addresses, uncommon locations, rare occupations, and combinations that could identify a person. Keep any re-identification key outside the test. Because the public product page and application disagree on mobile support, verify screen privacy, local browser storage, session expiry, and device loss on every permitted device rather than assuming feature parity.

A reproducible practitioner test

Prepare eight completed, de-identified cases already reviewed by the same practitioner. Include two straightforward cases, two close differentials, one sparse case, one case with ambiguous wording, one follow-up, and one case that should produce explicit uncertainty. Keep an answer packet outside both tools containing the original wording, accepted symptom structure, sources, rejected interpretations, final differential, and follow-up changes.

In simili.ai, record the input language, interpreted symptoms, ranked remedies, confidence output, visible explanation, source identity, engine mode, AI review, time, and allowance consumed. Repeat two cases with harmless wording changes and one with a material correction. Check whether rank changes are understandable, whether the product distinguishes missing evidence from low confidence, whether the Bayesian and AI views can be separated, and whether another practitioner can reconstruct the result without relying on the vendor's performance summary.

In Homeo AI, enter the same narratives. Record every proposed symptom and rubric accepted, edited, or rejected, each passage opened, how the remedy differential changes after correction, and whether a second practitioner can reproduce the accepted review. Reopen the follow-up and verify that the earlier rationale remains visible.

Score both products on narrative fidelity, source traceability, correction time, uncertainty handling, repeatability, export completeness, data deletion, device behavior, and continuity after the beta. Do not score agreement with a historical prescription as proof of accuracy. A ranked match can result from incomplete information or an unsupported mapping.

Known limits and clinical responsibility

A Bayesian label does not make uncertain inputs reliable. A confidence value is not clinical certainty. A large relationship count does not prove source quality, coverage, or the right interpretation for a particular case. A vendor preprint is not independent product validation, and semantic coherence is not therapeutic efficacy.

Homeo AI can also misunderstand a narrative, suggest an unsuitable rubric, omit relevant evidence, or create a plausible differential that needs correction. Source links and edit controls improve reviewability; they do not guarantee a correct conclusion.

Neither product replaces diagnosis, referral, an emergency-care decision, practitioner judgment, prescription, potency, dosage, or follow-up responsibility. Urgent, severe, or rapidly worsening symptoms require appropriate medical assessment. The practitioner remains accountable for the original case, every accepted interpretation and source, and every clinical action.

Conditional verdict

Choose Aquanta simili.ai if the practitioner specifically wants to test multilingual Bayesian remedy ranking with an AI review and receives satisfactory written answers about the conflicting limits, mobile support, data use, sources, confidence meaning, performance evaluation, export, deletion, and post-beta continuity. Treat the product metrics and research paper as sources of test questions, not proof of live clinical accuracy.

Choose Homeo AI if the priority is a reconstructable path from narrative through corrected symptom and rubric structure to inspected passages, remedy differentiation, and follow-up. If both are tested, keep the same answer packet and compare measured correction burden, traceability, uncertainty, and governance rather than the apparent authority of a ranked number.

Official sources checked

Product facts reviewed 2026-10-18. Confirm current features, prices, source libraries, and terms with the vendor.

Ready to take the next step?

Choose a time for a guided walkthrough, or open the app if you already have an account.

Book a call on Calendly - open the full scheduling calendar and choose the time that works for you.

Log in to the Homeo AI app - continue your saved case and follow-up workflow.

A 3-day trial is available only to first-time users who have not tried Homeo AI before.